Unclear whether your change needs a regulatory submission? We assess design, software, and process changes so your team can move forward with a clear, defensible regulatory path.
Make faster, defensible decisions on whether a change requires submission or can be managed internally.
Medical device teams often struggle with change impact assessment because there is no consistent way to evaluate regulatory impact. The real issue is the lack of a structured, defensible change impact assessment process. Without it, decisions become inconsistent, slow, and difficult to justify during audits.
This often results in inconsistent change-control practices and weak regulatory justification during audits.
Without structure:
⦿ Changes get stuck in the review process.
⦿ Teams submit too much out of fear.
⦿ Or, even worse, don't assess enough and put compliance at risk.
A structured change impact assessment ensures that each change is evaluated consistently for its regulatory significance.
This service is useful when:
⦿ The regulatory impact of a software change (SaMD) is unclear
⦿ A design or material change is being proposed
⦿ Manufacturing or supplier changes may affect compliance
⦿ Your team is unsure when to submit a new 510(k) for a change
⦿ QA, RA, and engineering disagree on the significance
⦿ Audit findings highlight weak medical device change control
This is typically useful for:
⦿ QA/RA leaders
⦿ Engineering/product leaders
⦿ Teams handling design, software, process, or supplier changes
⦿ Firms facing change-control audit findings
⦿ Does this change require a new submission?
⦿ Does it trigger updated verification or validation?
⦿ Does it affect intended use, indications, or labeling?
⦿ What documentation needs to be updated?
⦿ Can this be justified internally, or does it require submission?
Elexes enables:
⦿ Clear decisions on whether a change requires submission, documentation updates, or both.
⦿ Structured change impact assessment reports that are faster, consistent, and regulator-aligned
⦿ Making decisions across departments in a consistent way
⦿ Audit-ready justification
Outcome: Faster internal decision-making, reduced regulatory risk, and more confident change decisions.
⦿ Not full preparation for a 510(k) or EU MDR submission
⦿ Not an audit of ISO 13485 or a complete overhaul of the QMS
⦿ Not CAPA remediation
⦿ Review design, software, and process changes
⦿ Evaluate intended use, claims, and risk classification relevance
⦿ Compare the current process with regulatory expectations
⦿ Identify gaps in existing change-control logic, documentation, and decision criteria
⦿ Define when a change can be managed internally and when it may trigger regulatory submission or notification
⦿ Align with FDA and EU MDR expectations for regulatory impact assessment decisions
⦿ Create structured change impact assessment reports
⦿ Develop decision rationale, justification templates, and decision-support frameworks
⦿ Perform ongoing change assessments
⦿ Help with updating support documents
⦿ Support the preparation of documentation for audits, inspections, or regulatory questions where needed
⦿ Impact on intended use or indications
⦿ Changes to safety or performance
⦿ Software logic or algorithm updates (SaMD)
⦿ Design, material, or manufacturing changes
⦿ Validation or verification requirements
⦿ Submission triggers (FDA/EU MDR)
⦿ FDA (including when to submit a new 510(k) for a change)
⦿ EU MDR, including significant-change considerations where applicable
⦿ Selected additional markets where change documentation affects ongoing compliance
⦿ Software updates and patches
⦿ AI/algorithm changes
⦿ UI/UX changes in SaMD
⦿ Material or specification changes
⦿ Manufacturing or supplier changes
⦿ Labeling and claims updates
⦿ Cybersecurity-related changes
⦿ Change Impact Assessment Report
⦿ Regulatory Decision Rationale
⦿ Checklist aligned to FDA requirements
⦿ Submission decision flowchart
⦿ Documentation templates
⦿ Change tracking logs
If the change impact assessment is not handled correctly:
⦿ Incorrect change decisions increase audit and inspection exposure
⦿ Missed submission triggers create compliance risk
⦿ Weak documentation reduces audit defensibility
⦿ Over-submission leads to delays and unnecessary regulatory burden
⦿ Slow decision-making delays product updates
These issues directly impact speed, compliance, and operational efficiency.
Need a defensible decision on a current device change?
⦿ Absence of a decision-making framework
⦿ Misunderstanding of regulations
⦿ Weak documentation practices
⦿ Lack of cross-functional collaboration
⦿ Confidence issues in decision-making
⦿ Fear of noncompliance
⦿ No structured framework
⦿ Inconsistency in the internal review process
⦿ Teams may have SOPs but lack consistent decision logic
⦿ Similar changes are evaluated differently across reviewers
⦿ Weak justifications become visible only during audit or authority review
⦿ Discovery: Understand product, change type, and current process
⦿ Gap Assessment: Evaluate existing change control and documentation
⦿ Strategy: Define impact assessment framework
⦿ Execution: Perform change assessments and documentation
⦿ Review & Closure: Final validation and audit-ready records
⦿ Single change: usually takes about 3–5 business days
⦿ More complex assessments: depends on the scope and type of change
⦿ Ongoing support: handled on a weekly or monthly basis
Device: SaMD (software update)
Region: FDA
Problem: The team wasn’t sure if the update needed a new 510(k)
What We Did:
⦿ Reviewed the change in a structured way
⦿ Clarified the regulatory rationale
⦿ Documented everything in line with FDA expectations
Outcome:
⦿ Avoided unnecessary 510(k) submission
⦿ Accelerated internal decision-making and submission-readiness planning
⦿ Created audit-ready documentation
⦿ Strong alignment with FDA and EU MDR expectations
⦿ Extensive experience in change control of medical devices
⦿ Involvement of senior professionals in the decision-making process
⦿ Emphasis on creating defensible, audit-ready deliverables
Strong focus on structured decision logic, not just process execution
⦿ Design Change Documentation Support
⦿ FDA 510(k) Submission Support
⦿ Post-Market Surveillance Support
⦿ Complaint & PMS Governance Support
⦿ CAPA & QMS Health Assessment
⦿ Submission Readiness Assessment
⦿ Design-to-Regulatory Gap Analysis
Get Clarity on Your Change Impact Assessment
⦿ Quick expert review ⦿ Impact classification ⦿ Clear initial assessment and decision pathway within days
Not necessarily. Some changes can be managed internally with appropriate assessment and documentation.
Yes, including SaMD updates, patches, and algorithm changes.
Yes, including an FDA-aligned medical device change control checklist.
Both models are available.
Yes. We support EU MDR change assessments, including significant-change considerations where relevant.
Our process begins with an in-depth consultation where we learn about your medical device, its intended use, and your specific goals. This helps us tailor our assessment to your unique needs.
Our team of experts is well-versed in global medical device regulations, including FDA submissions, CE marking, TGA requirement, Health Canada approvals, ISO, and more. We stay up-to-date with the latest changes in the regulatory landscape.
We will conduct a comprehensive review of your existing documentation, including design files, clinical data, quality management systems, and risk assessments.
Our consultants will perform a gap analysis to identify any areas where your device may fall short of compliance. This forms the basis for our recommendations.
Based on our findings, we will provide you with detailed recommendations and a roadmap for achieving compliance. This may involve revising documentation, conducting additional testing, or making necessary design changes.
Our services don't stop with just the assessment. We offer ongoing support to guide you through the compliance process, helping you address any challenges that may arise.
Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.
Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.
Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.
At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.
We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.
We offer different services that will help you not only keep your product well in boundaries of regulations but also speed up the entire approval process. Some of these services are -
CEO Masterlink, Arizona
CEO Novasignal, Los Angeles
President ViDava, Florida
Sr. Exe Treedental, Hong Kong
Manager Outset Medical, California
CTO Jana Care, Massachusetts
MD Blackrock Pharma, England
VP Regulatory AliveCor, California
Owner Liz Inc., Arizona
CEO Radformation, New York
Never miss out on any important update on the regulatory & compliance industry across the globe. Subscribe to our newsletter now.
Copyright 2025, Elexes Medical Consulting Pvt. Ltd. All Rights Reserved
Working Hours : Monday to Friday 9:00 AM - 7:00 PM
Team Elexes 
